16.82
price up icon2.25%   0.37
after-market After Hours: 16.82
loading
Maze Therapeutics Inc stock is traded at $16.82, with a volume of 51,167. It is up +2.25% in the last 24 hours and up +47.41% over the past month. Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
See More
Previous Close:
$16.45
Open:
$16.49
24h Volume:
51,167
Relative Volume:
0.37
Market Cap:
$736.67M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.40%
1M Performance:
+47.41%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$16.14
$17.10
1-Week Range:
Value
$15.17
$18.67
52-Week Range:
Value
$6.71
$18.67

Maze Therapeutics Inc Stock (MAZE) Company Profile

Name
Name
Maze Therapeutics Inc
Name
Phone
(650) 850-5070
Name
Address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
Name
Employee
125
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MAZE's Discussions on Twitter

Compare MAZE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MAZE
Maze Therapeutics Inc
16.82 720.46M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-08-25 Initiated Wedbush Outperform

Maze Therapeutics Inc Stock (MAZE) Latest News

pulisher
11:24 AM

What analysts say about Maze Therapeutics Inc. stockExceptional profit potential - PrintWeekIndia

11:24 AM
pulisher
01:45 AM

Why Maze Therapeutics Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser

01:45 AM
pulisher
Jul 24, 2025

What makes Maze Therapeutics Inc. stock price move sharplyFree Stock Market Entry & Exit Signals - Newser

Jul 24, 2025
pulisher
Jul 24, 2025

What institutions are buying Maze Therapeutics Inc. stock nowFree Trading Strategy Suggestions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What drives Maze Therapeutics Inc. stock priceExtraordinary performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Maze Therapeutics Inc. Stock Analysis and ForecastTremendous wealth creation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

This Celsius Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

H.C. Wainwright initiates coverage on Maze Therapeutics stock with Buy rating - Investing.com UK

Jul 23, 2025
pulisher
Jul 23, 2025

Maze Therapeutics, Inc.: Buy Rating Initiated on Precision Nephrology Potential and Undervalued Stock - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Is Maze Therapeutics Inc. a good long term investmentHigh-velocity gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Maze Therapeutics, Inc.’s (NASDAQ:MAZE) Lock-Up Period To Expire on July 30th - Defense World

Jul 23, 2025
pulisher
Jul 19, 2025

how maze therapeutics inc. stock performs during market volatilityDaily Trade Opportunity - Newser

Jul 19, 2025
pulisher
Jul 15, 2025

How Maze Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Maze Therapeutics (NASDAQ:MAZE) Research Coverage Started at Wedbush - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

Q2 Earnings Estimate for Maze Therapeutics Issued By Wedbush - Defense World

Jul 11, 2025
pulisher
Jul 11, 2025

Brokerages Set Maze Therapeutics, Inc. (NASDAQ:MAZE) Target Price at $23.50 - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Maze Therapeutics Showcases Precision Medicine Pipeline at Major Kidney and Biotech Investor Conferences - Stock Titan

Jul 10, 2025
pulisher
Jul 10, 2025

Maze Therapeutics Soars 11.68% on Wedbush's Outperform Rating - AInvest

Jul 10, 2025
pulisher
Jul 08, 2025

Maze Therapeutics' Development Strategy Using Genetic Validation Seen as Promising, Wedbush Says - MarketScreener

Jul 08, 2025
pulisher
May 29, 2025

Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 21, 2025

Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail

May 21, 2025
pulisher
May 19, 2025

Positive Outlook for Maze Therapeutics: Buy Rating Reiterated Amid Promising Drug Developments and Strong Financial Position - TipRanks

May 19, 2025

Maze Therapeutics Inc Stock (MAZE) Financials Data

There is no financial data for Maze Therapeutics Inc (MAZE). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):